Patents and the right to health: an analysis of intellectual property discussions in the World Health Organization, between 2006 and 2016

• Autor(a) principal: Oliveira, Lucas Felipe Carvalho
• Data de Publicação: 2017
• Outros Autores: Santos, Alethele de Oliveira
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Cadernos Ibero-Americanos de Direito Sanitário (Online)
• Texto Completo: https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/437
• topic: Intellectual Property; Right to Health; World Health Organization; Pharmaceutical Products; Propiedad Intelectual; Derecho a la Salud; Organización Mundial de la Salud Producto Farmacéutico.; Propriedade Intelectual; Direito à Saúde; Organização Mundial da Saúde; Produtos Farmacêuticos.

Objective – To analyze the discussions held at WHO on intellectual property and public health, between 2006 and 2016. Results – The social functions of intellectual property were highlighted, however, observing that developing and less developed countries are not able to benefit from protection of intellectual property, so that the flexibilities in regulatory standards, such as the TRIPS Agreement and reaffirmed in the Doha Declaration, should be used. Final Considerations – Discussions on intellectual property, in particular on pharmaceuticals, are surrounded by controversies regarding the access of populations to essential medicines, the promotion of innovation and the transfer of technologies from developed to developing countries, It matters to point out that in the Brazilian context the recognition of intellectual property promoted an increase in the cost of pharmaceutical products, due to the monopoly, and becomes one of the barrier elements to the access and universalization of the right to health.